Rybelsus (Semaglutide) Tablets
  1. Home
  2. Rybelsus
  3. Rybelsus (Semaglutide) Tablets

Rybelsus (Semaglutide) Tablets

Rybelsus (Semaglutide) Tablets are prescription oral GLP-1 receptor agonist tablets used to improve glycemic control in adults with type 2 diabetes when combined with diet and exercise. They are formulated for once-daily oral administration, providing a convenient alternative to injectable GLP-1 therapies. The tablets deliver reliable and consistent semaglutide therapy to support effective diabetes management.

BUY NOW

Category

Rybelsus (Semaglutide) Tablets contain semaglutide, a GLP-1 receptor agonist that helps regulate blood glucose by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The oral tablet formulation is designed for once-daily administration, offering an effective non-injectable treatment option for adults with type 2 diabetes. Manufactured under stringent pharmaceutical quality standards, the tablets provide consistent therapeutic performance and are available in multiple strengths to support individualized treatment plans. Rybelsus (Semaglutide) Tablets should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Rybelsus (Semaglutide) Tablets
Active Ingredient Semaglutide
Dosage Form Oral Tablets
Route of Administration Oral
Dosing Frequency Once Daily (As Prescribed)
Storage Store at Room Temperature as Directed

Product Also Known As

Rybelsus Tablets, Semaglutide Tablets, Oral Semaglutide Tablets, GLP-1 Oral Tablets, Rybelsus Oral Tablets, Semaglutide Diabetes Tablets, Type 2 Diabetes Tablets